vs
DT Midstream, Inc.(DTM)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
DT Midstream, Inc.的季度营收约是REPLIGEN CORP的1.6倍($317.0M vs $197.9M),DT Midstream, Inc.净利率更高(35.0% vs 6.7%,领先28.3%),DT Midstream, Inc.同比增速更快(27.3% vs 13.6%),DT Midstream, Inc.自由现金流更多($30.0M vs $17.6M),过去两年DT Midstream, Inc.的营收复合增速更高(14.9% vs 14.4%)
ONEOK是美国油气中游运营商,总部位于俄克拉荷马州塔尔萨,为油气行业提供收集、处理、分馏、运输及存储服务,是财富500强企业及标普500指数成分股。公司1906年成立时名为俄克拉荷马天然气公司,1980年更为现名。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
DTM vs RGEN — 直观对比
营收规模更大
DTM
是对方的1.6倍
$197.9M
营收增速更快
DTM
高出13.7%
13.6%
净利率更高
DTM
高出28.3%
6.7%
自由现金流更多
DTM
多$12.4M
$17.6M
两年增速更快
DTM
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $317.0M | $197.9M |
| 净利润 | $111.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 49.2% | 9.0% |
| 净利率 | 35.0% | 6.7% |
| 营收同比 | 27.3% | 13.6% |
| 净利润同比 | 52.1% | 143.9% |
| 每股收益(稀释后) | $1.07 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DTM
RGEN
| Q4 25 | $317.0M | $197.9M | ||
| Q3 25 | $314.0M | $188.8M | ||
| Q2 25 | $309.0M | $182.4M | ||
| Q1 25 | $303.0M | $169.2M | ||
| Q4 24 | $249.0M | $174.1M | ||
| Q3 24 | $248.0M | $154.9M | ||
| Q2 24 | $244.0M | $154.1M | ||
| Q1 24 | $240.0M | $151.3M |
净利润
DTM
RGEN
| Q4 25 | $111.0M | $13.3M | ||
| Q3 25 | $115.0M | $14.9M | ||
| Q2 25 | $107.0M | $14.9M | ||
| Q1 25 | $108.0M | $5.8M | ||
| Q4 24 | $73.0M | $-30.3M | ||
| Q3 24 | $88.0M | $-654.0K | ||
| Q2 24 | $96.0M | $3.3M | ||
| Q1 24 | $97.0M | $2.1M |
毛利率
DTM
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
DTM
RGEN
| Q4 25 | 49.2% | 9.0% | ||
| Q3 25 | 49.4% | 8.9% | ||
| Q2 25 | 50.2% | 7.6% | ||
| Q1 25 | 48.8% | 3.9% | ||
| Q4 24 | 45.4% | -17.7% | ||
| Q3 24 | 49.2% | -5.1% | ||
| Q2 24 | 53.3% | 1.0% | ||
| Q1 24 | 51.7% | 1.3% |
净利率
DTM
RGEN
| Q4 25 | 35.0% | 6.7% | ||
| Q3 25 | 36.6% | 7.9% | ||
| Q2 25 | 34.6% | 8.2% | ||
| Q1 25 | 35.6% | 3.4% | ||
| Q4 24 | 29.3% | -17.4% | ||
| Q3 24 | 35.5% | -0.4% | ||
| Q2 24 | 39.3% | 2.2% | ||
| Q1 24 | 40.4% | 1.4% |
每股收益(稀释后)
DTM
RGEN
| Q4 25 | $1.07 | $0.24 | ||
| Q3 25 | $1.13 | $0.26 | ||
| Q2 25 | $1.04 | $0.26 | ||
| Q1 25 | $1.06 | $0.10 | ||
| Q4 24 | $0.73 | $-0.55 | ||
| Q3 24 | $0.90 | $-0.01 | ||
| Q2 24 | $0.98 | $0.06 | ||
| Q1 24 | $0.99 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $54.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $4.7B | $2.1B |
| 总资产 | $10.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
DTM
RGEN
| Q4 25 | $54.0M | $767.6M | ||
| Q3 25 | $98.0M | $748.7M | ||
| Q2 25 | $74.0M | $708.9M | ||
| Q1 25 | $83.0M | $697.2M | ||
| Q4 24 | $68.0M | $757.4M | ||
| Q3 24 | $77.0M | $784.0M | ||
| Q2 24 | $73.0M | $809.1M | ||
| Q1 24 | $41.0M | $780.6M |
总债务
DTM
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.4B | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
DTM
RGEN
| Q4 25 | $4.7B | $2.1B | ||
| Q3 25 | $4.7B | $2.1B | ||
| Q2 25 | $4.7B | $2.1B | ||
| Q1 25 | $4.6B | $2.0B | ||
| Q4 24 | $4.6B | $2.0B | ||
| Q3 24 | $4.2B | $2.0B | ||
| Q2 24 | $4.2B | $2.0B | ||
| Q1 24 | $4.2B | $2.0B |
总资产
DTM
RGEN
| Q4 25 | $10.1B | $2.9B | ||
| Q3 25 | $10.1B | $2.9B | ||
| Q2 25 | $10.0B | $2.9B | ||
| Q1 25 | $9.9B | $2.9B | ||
| Q4 24 | $9.9B | $2.8B | ||
| Q3 24 | $8.6B | $2.8B | ||
| Q2 24 | $9.0B | $2.9B | ||
| Q1 24 | $9.0B | $2.8B |
负债/权益比
DTM
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.72× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $161.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $30.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 9.5% | 8.9% |
| 资本支出强度资本支出/营收 | 41.3% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.45× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $441.0M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
DTM
RGEN
| Q4 25 | $161.0M | $25.7M | ||
| Q3 25 | $274.0M | $48.1M | ||
| Q2 25 | $185.0M | $28.6M | ||
| Q1 25 | $247.0M | $15.0M | ||
| Q4 24 | $152.0M | $39.2M | ||
| Q3 24 | $205.0M | $49.3M | ||
| Q2 24 | $165.0M | $42.2M | ||
| Q1 24 | $241.0M | $44.7M |
自由现金流
DTM
RGEN
| Q4 25 | $30.0M | $17.6M | ||
| Q3 25 | $131.0M | $43.4M | ||
| Q2 25 | $104.0M | $21.5M | ||
| Q1 25 | $176.0M | $11.4M | ||
| Q4 24 | $62.0M | $33.6M | ||
| Q3 24 | $124.0M | $42.3M | ||
| Q2 24 | $84.0M | $37.4M | ||
| Q1 24 | $143.0M | $36.4M |
自由现金流率
DTM
RGEN
| Q4 25 | 9.5% | 8.9% | ||
| Q3 25 | 41.7% | 23.0% | ||
| Q2 25 | 33.7% | 11.8% | ||
| Q1 25 | 58.1% | 6.8% | ||
| Q4 24 | 24.9% | 19.3% | ||
| Q3 24 | 50.0% | 27.3% | ||
| Q2 24 | 34.4% | 24.3% | ||
| Q1 24 | 59.6% | 24.0% |
资本支出强度
DTM
RGEN
| Q4 25 | 41.3% | 4.1% | ||
| Q3 25 | 45.5% | 2.5% | ||
| Q2 25 | 26.2% | 3.9% | ||
| Q1 25 | 23.4% | 2.1% | ||
| Q4 24 | 36.1% | 3.2% | ||
| Q3 24 | 32.7% | 4.5% | ||
| Q2 24 | 33.2% | 3.1% | ||
| Q1 24 | 40.8% | 5.5% |
现金转化率
DTM
RGEN
| Q4 25 | 1.45× | 1.93× | ||
| Q3 25 | 2.38× | 3.23× | ||
| Q2 25 | 1.73× | 1.92× | ||
| Q1 25 | 2.29× | 2.57× | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 1.72× | 12.70× | ||
| Q1 24 | 2.48× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DTM
| Pipeline Segment | $173.0M | 55% |
| Gathering Segment | $144.0M | 45% |
RGEN
暂无分部数据